Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis

• Richard Fristedt ,

  * E-mail: richard.fristedt@med.lu.se

  Affiliation Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden

  ⨯
• Jacob Elebro,

  Affiliation Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden

  ⨯
• Alexander Gaber,

  Affiliation Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden

  ⨯
• Liv Jonsson,

  Affiliation Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden

  ⨯
• Margareta Heby,

  Affiliation Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden

  ⨯
• Yulyana Yudina,

  Affiliation Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden

  ⨯
• Björn Nodin,

  Affiliation Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden

  ⨯
• Mathias Uhlén,

  Affiliations Science for Life Laboratory, Royal Institute of Technology, 171 21 Stockholm, Sweden, School of Biotechnology, AlbaNova University Center, Royal Institute of Technology, 106 91 Stockholm, Sweden

  ⨯
• Jakob Eberhard,

  Affiliation Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden

  ⨯
• Karin Jirström

  Affiliation Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden

  ⨯